News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Joseph Grossman: Botensilimab is effective against Tumors Poorly Responsive to Conventional Immunotherapy
Joseph Grossman/X
Oct 22, 2024, 14:57

Joseph Grossman: Botensilimab is effective against Tumors Poorly Responsive to Conventional Immunotherapy

Joseph Grossman, Vice President of Early Clinical Development at Agenus,  shared a post on LinkedIn:

“The final version of our recent Cancer Discovery paper came out today “Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy”.
I couldn’t be prouder of our team at Agenus, or more excited for the future of oncology.”

Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy 

Authors: Dhan Chand, et al.

Joseph Grossman

AACR Agenus cancer cancer awareness cancer care Cancer Discovery Dhan Chand fight against cancer Global fight against cancer immunotherapy Joseph Grossman OncoDaily Oncology
Special Coverage
Blog
Oct 25, 2024, 09:54
Upcoming MASCC webinar on Early-Stage Curative Care
Blog
Oct 25, 2024, 09:34
What are the biggest challenges in cancer care today? - UICC
Blog
Oct 25, 2024, 09:28
Lyda Hill Philanthropies Was Honored with the American Cancer Society Philanthropist of the Year Award
Dialogues
Oct 25, 2024, 09:05
ASCO24 Updates: Dr. Xin Hu on Early Palliative Care in Advanced Cancer
Blog
Oct 25, 2024, 09:02
Cancer vaccine can block tumor progression at the early lesion stage - Vanderbilt-Ingram Cancer Center
Blog
Oct 25, 2024, 08:58
NCDs prevention goes beyond treatment - Medicaid CF Programs
Blog
Oct 25, 2024, 08:52
Patrick Hwu: Important conversation with Dana Ataya about Breast Cancer screening
Blog
Oct 25, 2024, 08:51
Nirmit Kumar: Great overview of the history of Antibody Drug Conjugates by Raffaele Colombo et al.
Insight
Oct 25, 2024, 08:49
Navigating a job interview in the industry - EACR
Blog
Oct 25, 2024, 08:46
Vivek Subbiah: SCRI Phase 1 Denver DDU is celebrating its 10th anniversary
Blog
Oct 25, 2024, 08:43
'Choosing Wisely Africa' - KESHO
Blog
Oct 25, 2024, 08:42
Phillip Scheinberg: Honored to have Dr. Rami Komrokji at Heme Noon Conference